Publication References

Kidney Publications

  1. Validation of a gene expression signature to measure immune quiescence in kidney transplant recipients in the CLIA setting. Biomark Med. 2022 Jun;16(8):647-661.
  2. Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation. Kidney360. 2021 Sep 28;2(12):1998-2009.
  3. Longitudinal Evaluation of Donor-Derived Cell free DNA in Pediatric Kidney Transplantation. Clin J Am Soc Nephrol. 2022 Nov;17(11):1646-1655. PMID: 36302566
  4. Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation. Nature Scientific Reports. 2022 Sep 5;12(1):15061.
  5. Correlation of Donor-derived Cell-free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies. Transplantation. 2022 May 1;106(5):1061-1070. PMID: 34075006
  6. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int. 2021 Dec 22;S0085-2538(21)01168-6
  7. Association between dd-cfDNA levels, de novo donor specific antibodies, and eGFR decline: An analysis of the DART cohort. Clinical Transplantation. 2021;35:e14402.
  8. Donor-Derived Cell Free DNA: Is It All the Same? Kidney360. 2020 Jun 19;1(10):1118-1123.PMID: 35368782
  9. Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy. Transplant Direct. 2020 Oct 23;6(11):e622. PMID: 33134498
  10. High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury. Am J Transplant. 2020;00:1-8. PMID 32056331.
  11. Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA. Transpl Int. 2020 Jun 11. doi: 10. 1111/tri.13673.
  12. Donor-Derived Cell Free DNA (dd-cfDNA) for Detection of Allograft Rejection in Pediatric Kidney Transplants. Pediatric Transplant. 2020 Nov 20;e13850.
  13. Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA. Am J Transplant. 2019;19:1597–1598.
  14. Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients. Transplant Direct. 2018;4:e379. PMID 30234148.
  15. Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications. J Appl Lab Med. 2017 Nov 1;2(3):309-321. PMID: 33636851
  16. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol. 2017;28:2221-2232. PMID 28280140.
  17. Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients. J Mol Diag. 2016 Nov 1;18(6):890-902.

Heart Publications

  1. Evolving the surveillance and workup of heart transplant rejection: A real-world analysis of the Molecular Microscope Diagnostic System. Am J Transplant. May 05 2022; doi:10.1111/ajt.17087
  2. Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients – A Proof-of-Concept Study. Front Immunol. 2022;13:825108. doi:10.3389/fimmu.2022.825108
  3. Sparing the Prod: Providing an Alternative to Endomyocardial Biopsies With Noninvasive Surveillance After Heart Transplantation During COVID-19. CJC Open. May 2022;4(5):479-487.
  4. Combining donor derived cell free DNA and gene expression profiling for non-invasive surveillance after heart transplantation. Clin Transplant. May 12 2022:e14699. doi:10.1111/ctr.14699
  5. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation. Pediatr Transplant. Feb 2022;26(1):e14124. doi:10.1111/petr.14124
  6. Single-Center Utilization of Donor-Derived Cell-Free DNA Testing in the Management of Heart Transplant Patients. Clin Transplant. 2021 Feb 19;e14258. doi: 10.1111/ctr.14258.
  7. Donor derived cell free DNA is Associated with Cardiac Allograft Vasculopathy. Clin Transplant. 2020 Dec 25;e14206. doi: 10.1111/ctr.14206.
  8. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study. Am J Transplant. 2019;19:2889–2899.
  9. Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients. J Mol Diag. 2016 Nov 1;18(6):890-902.

Lung Publications

  1. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients. J Appl Lab Med. 2022 Jan 12;jfab171. doi: 10.1093/jalm/jfab171.
  2. Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care. J Heart Lung Transplant. 2022 doi 10.1016/j.healun.2021.12.009
  3. Donor-derived Cell-free DNA Levels by Next Generation Targeted Sequencing are Elevated in Allograft Rejection after Lung Transplantation. ERJ Open Res. 2021; 7:00462-2020
  4. Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data. Transplant Direct. 2020 Sep 24;6(10):e608.